Effectiveness of Electroacupuncture at Xuanzhong (GB39) and Tongli (HT5) Points in Post-Stroke Aphasia

Participants and Methods: A randomized, single‐blind, controlled trial will be conductedat the Military Medical Hospital 175, HCMC Hospital Orthopedics and Rehabilitation, andHCMC Hospital for Rehabilitation ‐ Professional Diseases, involving patients aged 18 to75 years diagnosed with post‐stroke aphasia (PSA). Participants must meet definedinclusion criteria and not fall under any exclusion criteria, such as severe comorbidheart, liver, or kidney failure.Randomization and Grouping: Participants will be randomly assigned into two groups in a1:1 ratio using block randomization with stratification by study site. The interventiongroup will receive electroacupuncture at the Xuanzhong (GB39) and Tongli (HT5) acupoints,combined with standardized speech therapy and basic medical treatment. The control groupwill receive electroacupuncture at non‐acupoint locations, combined with the samestandardized speech therapy and basic medical treatment.Procedure and Assessments: Both groups will receive 4 weeks of intervention, withelectroacupuncture sessions conducted once daily, 5 days per week. Speech therapy will beperformed daily for 30 minutes, 5 days per week. Clinical outcomes including the BDAEscale and ART will be assessed at baseline (T0), after 2 weeks (T1), and 1 month aftertreatment (T2). Quality of life (SAQOL‐39) will be assessed at baseline (T0), 1 monthafter treatment (T2), and at a 3‐month follow‐up (T3). Adverse effects, such as localpain, bleeding, bruising, dizziness, or needle fainting, will be carefully monitored andrecorded throughout the study period.